Starna Scientific Limited

Active00793931ManufacturingIncorporated 28 Feb 1964 · Hainault

The principal activity of the company is the development and manufacture of traceable reference materials and precision optical components for laboratory and instrument users. Sales are achieved through a mix of direct relationships and established distributors across mature markets. Starna’s reputation and differentiation are built on accreditation (ISO 9001, ISO/IEC 17025, and ISO 17034) and metrology expertise supported by robust certification. The model emphasises quality, dependable lead times, and technical support. Trading conditions were mixed, with steady demand in core lines and selective input cost pressure. Revenue was broadly resilient at £10.0m ( 2024 : £10.16m). Gross margin improved to 50% ( 2024 : 48%), reflecting an evolving product mix and disciplined cost control. Our ISO 9001, ISO/IEC 17025, and ISO 17034 accreditations continue to underpin customer confidence and support pricing power through demonstrable quality and traceability. The company considers both revenue and gross margin as key performance indicators. UK domestic tax changes have further increased labour costs due to higher NIC rates and reduced thresholds. Conversely, potential government investment in technology could support future demand for our products. Operating environment and logistics. Disruption to global sea freight routes had a limited impact on outbound sales. However, certain raw materials experienced longer inbound lead times and cost variability. These effects were managed through forward purchasing, alternative sourcing where appropriate and pragmatic inventory buffers. Overlaps between raw material chains drove price and availability pressures for specific inputs. We mitigate this through supplier diversification and the qualification of secondary sources where possible.

Revenue

£10.2m

▼ -12.1% vs prior ~12m period

Profit after tax

£868k

Margin 8.5%

Employees

98

▼ -3.0% vs prior ~12m period

Net assets

£16.7m

Total assets £19.0m

Financial history

Revenue by accounting period

6 periods available · ▲ growth ▼ decline

Apr 2020
£9.0m
Apr 2021
£11.6m▲ +28.9%
Apr 2022
£10.2m▼ -12.1%
Apr 2023
Not available
Apr 2024
Not available
Apr 2025
Not available
Period endRevenueGrowthProfit before taxEmployeesNet assets
30 Apr 2025——£2.3m98£16.7m
30 Apr 2024——£1.5m101£15.8m
30 Apr 2023——£1.0m103£15.1m
30 Apr 2022£10.2m▼ -12.1%£1.1m100£14.7m
30 Apr 2021£11.6m▲ +28.9%£4.8m97£14.3m
30 Apr 2020£9.0m—£2.9m95£11.4m

Latest available figures

Period ending 30 Apr 2022. “Not available” means the figure is not in the accounts we hold. We do not estimate missing figures.

Profit & loss

Revenue
£10.2m
Gross profit
Not available
Operating profit
£865k
Profit before tax
£1.1m
Profit after tax
£868k

Balance sheet

Total assets
£19.0m
Cash
£7.0m
Total liabilities
£2.3m
Net assets
£16.7m
Revenue per employee
Not available

Similar companies

CompanyRevenueGrowth
Harlette Capital Limited
08565376
£100.0m– 0.0%
Usp Steels Limited
10437761
£99.2m▲ +2.7%
Pickstock Foods Ltd
11412792
£97.3m▲ +18.0%
Crescent Pharma Limited
04750933
£96.5m▼ -8.4%
B.H.C. Limited
NI029649
£96.0m▼ -31.0%

Other manufacturing companies in London

CompanyRevenueGrowth
Ds Smith Packaging Limited
00630681
£687.2m▼ -9.8%
Baird & Co. Limited
02269558
£471.1m▲ +25.5%
Vapes-Bars Ltd
13540609
£162.6m▼ -5.4%
Keter UK Limited
04992337
£113.0m▼ -11.2%
Cepac Limited
03373762
£111.2m▼ -4.6%